D + Q significantly reduced the proportion of p16+αSMA+ myofibroblasts and p16+CD31+ endothelial cells in the atria of MI rats, reversed atrial remodeling, and decreased the atrial fibrillation induction rate (from 89% to 0%). The gene discussed is CDKN2A; the disease is atrial fibrillation.